Identification of Human MicroRNA-Like Sequences Embedded within the Protein-Encoding Genes of the Human Immunodeficiency Virus

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Holland, Bryan ^a   Wong, Jonathan ^a   Li, Meng ^a   Rasheed, Suraiya ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GAG PROTEIN; GLYCOPROTEIN GP 120; MESSENGER RNA; MICRORNA; MICRORNA 15B; MICRORNA 16 1; MICRORNA 16 2; MICRORNA 195; MICRORNA 30D; MICRORNA 30E; MICRORNA 374A; MICRORNA 424; POL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASE MISPAIRING; CD4 LYMPHOCYTE COUNT; COMPUTER MODEL; ENVELOPE GENE; GENE LOCATION; GENE SEQUENCE; GENETIC CODE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; RNA ANALYSIS; RNA SEQUENCE; STRUCTURAL GENE; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS STRAIN;

DATABASES, NUCLEIC ACID; GENOME, VIRAL; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MICRORNAS; RNA, VIRAL;

EID: 84874772478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058586     Document Type: Article

References (47)

1. Siomi H, Siomi MC, (2010) Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38: 323-332.
2. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
3. Dai Y, Huang YS, Tang M, Lv TY, Hu CX, et al. (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16: 939-946.
4. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Doench JG, Sharp PA, (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511.
6. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
7. Wang X, Ye L, Hou W, Zhou Y, Wang YJ, et al. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113: 671-674.
8. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
9. Kincaid RP, Burke JM, Sullivan CS, (2012) RNA virus microRNA that mimics a B-cell oncomiR. Proc Natl Acad Sci U S A 109: 3077-3082.
10. Hariharan M, Scaria V, Pillai B, Brahmachari SK, (2005) Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 337: 1214-1218.
11. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, et al. (2008) Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5: 117.
12. Yeung ML, Bennasser Y, Myers TG, Jiang G, Benkirane M, et al. (2005) Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2: 81.
13. Houzet L, Jeang KT, (2011) MicroRNAs and human retroviruses. Biochim Biophys Acta 1809(11-12): 686-693.
14. Gupta A, Nagilla P, Le HS, Bunney C, Zych C, et al. (2011) Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1). PLoS One 6: e22730.
15. Pilakka-Kanthikeel S, Saiyed ZM, Napuri J, Nair MP, (2011) MicroRNA: implications in HIV, a brief overview. J Neurovirol 17: 416-423.
16. Bennasser Y, Le SY, Yeung ML, Jeang KT, (2004) HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 1: 43.
17. Lin J, Cullen BR, (2007) Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol 81: 12218-12226.
18. Omoto S, Fujii YR, (2005) Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol 86: 751-755.
19. Kaul D, Ahlawat A, Gupta SD, (2009) HIV-1 genome-encoded hiv1-mir-H1 impairs cellular responses to infection. Mol Cell Biochem 323: 143-148.
20. Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, et al. (2009) HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6: 18.
21. Ouellet DL, Plante I, Landry P, Barat C, Janelle ME, et al. (2008) Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 36: 2353-2365.
22. Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L, et al. (2009) Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 37: 6575-6586.
23. Schopman NC, Willemsen M, Liu YP, Bradley T, van Kampen A, et al. (2012) Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 40: 414-427.
24. Hakim ST, Alsayari M, McLean DC, Saleem S, Addanki KC, et al. (2008) A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses. Biochem Biophys Res Commun 369: 357-362.
25. Rasheed S, Yan JS, Lau A, Chan AS, (2008) HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One 3: e3003.
26. Rasheed S, Yan JS, Hussain A, Lai B, (2009) Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways. J Transl Med 7: 75.
27. Gong TW, Besirli CG, Lomax MI, (2001) MACF1 gene structure: a hybrid of plectin and dystrophin. Mamm Genome 12: 852-861.
28. Wang W, Guo J, Yu D, Vorster PJ, Chen W, et al. (2012) A Dichotomy in Cortical Actin and Chemotactic Actin Activity between Human Memory and Naive T Cells Contributes to Their Differential Susceptibility to HIV-1 Infection. J Biol Chem 287: 35455-35469.
29. Boeras DI, Hraber PT, Hurlston M, Evans-Strickfaden T, Bhattacharya T, et al. (2011) Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proc Natl Acad Sci U S A 108: E1156-1163.
30. Flavin RJ, Smyth PC, Laios A, O'Toole SA, Barrett C, et al. (2009) Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Mod Pathol 22: 197-205.
31. Sun G, Rossi JJ, (2011) MicroRNAs and their potential involvement in HIV infection. Trends Pharmacol Sci 32: 675-681.
32. Li D, Zhao Y, Liu C, Chen X, Qi Y, et al. (2011) Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730.
33. Zhu H, Yang Y, Wang Y, Li J, Schiller PW, et al. (2011) MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res 92: 75-84.
34. Zhu HC, Wang LM, Wang M, Song B, Tan S, et al. (2012) MicroRNA-195 downregulates Alzheimer's disease amyloid-beta production by targeting BACE1. Brain Res Bull 88(6): 596-601.
35. Chen H, Untiveros GM, McKee LA, Perez J, Li J, et al. (2012) Micro-RNA-195 and-451 regulate the LKB1/AMPK signaling axis by targeting MO25. PLoS One 7: e41574.
36. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
37. Bennasser Y, Yeung ML, Jeang KT, (2006) HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem 281: 27674-27678.
38. Pantophlet R, Burton DR, (2006) GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24: 739-769.
39. Cheng-Mayer C, Quiroga M, Tung JW, Dina D, Levy JA, (1990) Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol 64: 4390-4398.
40. Morikita T, Maeda Y, Fujii S, Matsushita S, Obaru K, et al. (1997) The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism. AIDS Res Hum Retroviruses 13: 1291-1299.
41. van Gils MJ, Bunnik EM, Boeser-Nunnink BD, Burger JA, Terlouw-Klein M, et al. (2011) Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. J Virol 85: 6986-6995.
42. Rasheed S, Norman GL, Gill PS, Meyer PR, Cheng L, et al. (1986) Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Virology 150: 1-9.
43. Meissner EG, Coffield VM, Su L, (2005) Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry. Virology 336: 184-197.
44. Antonov AV, Dietmann S, Wong P, Lutter D, Mewes HW, (2009) GeneSet2miRNA: finding the signature of cooperative miRNA activities in the gene lists. Nucleic Acids Res 37: W323-328.
45. Karlin S, Altschul SF, (1990) Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc Natl Acad Sci U S A 87: 2264-2268.
46. Higgins DG, Sharp PM, (1989) Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci 5: 151-153.
47. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.